| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,996 |
11,633 |
$365K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,146 |
3,443 |
$172K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
3,375 |
2,943 |
$86K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,590 |
1,419 |
$65K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,658 |
2,227 |
$41K |
| 87428 |
|
666 |
605 |
$29K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,227 |
2,858 |
$27K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,835 |
1,519 |
$25K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
98 |
87 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
272 |
247 |
$5K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
326 |
255 |
$5K |
| T1015 |
Clinic visit/encounter, all-inclusive |
13,396 |
11,132 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
103 |
85 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
800 |
676 |
$850.93 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
73 |
51 |
$784.12 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
25 |
19 |
$755.25 |
| 87807 |
|
57 |
42 |
$355.68 |
| 99401 |
|
17 |
15 |
$153.84 |
| 80305 |
|
14 |
13 |
$58.97 |
| 96127 |
|
21 |
14 |
$40.88 |
| 81003 |
|
110 |
93 |
$7.47 |